Viewing Study NCT01032395

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-02-02 @ 9:54 PM
Study NCT ID: NCT01032395
Status: COMPLETED
Last Update Posted: 2013-06-14
First Post: 2009-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
Sponsor: Chiltern Pesquisa Clinica Ltda
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None H1N1 Influenza Virus View
None Chronic Pulmonary Disease View
None Chronic Heart Disease View
None Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None H1N1 View
None Pulmonary Disease View
None Heart Disease View
None Diabetes View
None Influenza View
None immunogenicity View
None safety View
None tolerability View